Trials / Unknown
UnknownNCT02857855
Postoperative Supplemental Oxygen in Liver Transplantation
The Impact of Postoperative Oxygen Therapy on the Results of Liver Transplantation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 193 (actual)
- Sponsor
- Medical University of Warsaw · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this prospective randomized controlled trial is to evaluate the impact of high concentration supplemental postoperative oxygen therapy on short-term and long-term results of liver transplantation, particularly with respect to infections and biliary complications.
Detailed description
The aim of this prospective randomized controlled trial is to evaluate the impact of high concentration supplemental postoperative oxygen therapy on short-term and long-term results of liver transplantation, particularly with respect to infections and biliary complications. A total of 296 patients immediately after liver transplantation will be randomly assigned to receive either 80% (high concentration) or 28% (controls) fraction of inspired oxygen for 6 hours after surgery with a 1:1 allocation ratio. Patients will be blinded to the type of received intervention. Randomization will be stratified by the Child-Turcotte-Pugh classification. Both groups will be compared to short- and long-term outcome measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 80% fraction of inspired oxygen for 6 postoperative hours | 80% fraction of inspired oxygen delivered for 6 postoperative hours, either by a nonrebreathing facemask with a reservoir or by a respirator |
| PROCEDURE | 28% fraction of inspired oxygen for 6 postoperative hours | 28% fraction of inspired oxygen delivered for 6 postoperative hours, either by a Venturi facemask or by a respirator |
Timeline
- Start date
- 2016-07-27
- Primary completion
- 2020-04-07
- Completion
- 2025-04-01
- First posted
- 2016-08-05
- Last updated
- 2023-01-12
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02857855. Inclusion in this directory is not an endorsement.